We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3231:TSENomura Real Estate Holdings, Inc. Analysis

Data as of 2026-03-11 - not real-time

NT$133.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Wistron Corp. (3231.TW) is trading at TWD 133, comfortably above its 20‑day SMA (130.4) but still below the 50‑day SMA (138.3), indicating a neutral short‑term trend. The RSI sits at 50.3 and the MACD histogram is positive, suggesting a modest bullish momentum supported by increasing volume. Valuation metrics are compelling: a trailing P/E of 16.3 is well below the industry average of 37, and a forward P/E of 10.6 points to significant upside, reflected in the analyst median target of TWD 190 – roughly a 44% upside from current levels. The dividend yield of 2.95% and a payout ratio under 50% are attractive, yet the sustainability is questionable given negative operating cash flow (‑TWD 158 B) and free cash flow (‑TWD 204 B), coupled with a high debt‑to‑equity of 148.7 and total debt of TWD 337 B. The stock’s beta of 0.67 and a volatility of 34.9% over the past 30 days imply lower market sensitivity but higher price swings. The Fear & Greed Index at 77.8 (“Extreme Greed”) signals strong market appetite, but geopolitical exposure across the U.S., Europe, and China adds geographic risk. Overall, the stock appears undervalued on a price basis but carries notable financial and operational risks.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive MACD histogram and increasing volume indicate near‑term bullish pressure
  • Undervalued P/E relative to industry peers
  • Attractive dividend yield despite cash‑flow concerns

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 10.6 suggests earnings acceleration
  • Analyst median price target of TWD 190 implies ~44% upside
  • Low beta reduces market‑wide volatility exposure

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage (debt‑to‑equity 148.7) and negative cash flows pose solvency risk
  • Geopolitical exposure across Taiwan, China, U.S., and Europe
  • Sustainable dividend uncertain without cash‑flow improvement

Key Metrics & Analysis

Financial Health

Revenue Growth108.30%
Profit Margin1.39%
P/E Ratio16.3
ROE25.49%
ROA5.36%
Debt/Equity148.67
P/B Ratio2.6
Op. Cash FlowNT$-158478286848
Free Cash FlowNT$-204019400704
Industry P/E37.0

Technical Analysis

TrendNeutral
RSI50.3
SupportNT$123.50
ResistanceNT$139.50
MA 20NT$130.43
MA 50NT$138.29
MA 200NT$129.73
MACDBullish
VolumeIncreasing
Fear & Greed Index77.82

Valuation

Target PriceNT$192.23
Upside/Downside44.53%
GradeUndervalued
TypeValue
Dividend Yield2.95%

Risk Assessment

Beta0.67
Volatility34.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.